1-3 of 3
Irena Tan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Do PROs Tell the Whole Story? Differential Outcomes Based on Patient-Reported Outcomes (PROs) Versus Performance-Based Metrics (PBM) on Cognition for Patients Receiving Chimeric Antigen Receptor (CAR)-T Cell Therapy

Irena Tan, Rachel Cusatis, Emma Crawford, Aline Thiengmany, Claire Piehowski, Idayat Akinola, Juliana Craig, Sheila Lahijani, Matthew J. Frank, Nirav N. Shah, Anita D'Souza, David B. Miklos, Lori Muffly, Kathryn E Flynn, Surbhi Sidana
Journal: Blood
Blood (2021) 138 (Supplement 1): 3043.
https://doi.org/10.1182/blood-2021-145746
Published: 2021
Journal Articles

Worsening Financial Toxicity Among Patients Receiving Chimeric Antigen Receptor t-Cell (CAR-T) Therapy: A Mixed Methods Longitudinal Study

Rachel Cusatis, Irena Tan, Claire Piehowski, Idayat Akinola, Emma Crawford, Juliana Craig, Aline Thiengmany, Matthew J. Frank, David B. Miklos, Nirav N. Shah, Anita D'Souza, Jennifer M Knight, Lori Muffly, Kathryn E Flynn, Surbhi Sidana
Journal: Blood
Blood (2021) 138 (Supplement 1): 567.
https://doi.org/10.1182/blood-2021-146032
Published: 2021
Journal Articles

Heterogeneous Definitions of Secondary Acute Myeloid Leukemia (AML) Yield Distinct Outcomes in Response to First-Line Treatment with Hypomethylating Agents (HMA) and Venetoclax (Ven)

Irena Tan, Matthew Schwede, Paul Phan, Raymond Yin, Tian Y Zhang, Gabriel N. Mannis
Journal: Blood
Blood (2021) 138 (Supplement 1): 1216.
https://doi.org/10.1182/blood-2021-147886
Published: 2021